News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
558,051 Results
Type
Article (40529)
Company Profile (80)
Press Release (517430)
Multimedia
Podcasts (61)
Webinars (13)
Section
Business (152761)
Career Advice (2460)
Deals (27969)
Drug Delivery (102)
Drug Development (73043)
Employer Resources (142)
FDA (13748)
Job Trends (12261)
News (272799)
Policy (27245)
Tag
Academia (2544)
Academic (1)
Accelerated approval (13)
Adcomms (30)
Allergies (101)
Alliances (38605)
ALS (127)
Alzheimer's disease (1536)
Antibody-drug conjugate (ADC) (172)
Approvals (13782)
Artificial intelligence (328)
Autoimmune disease (41)
Automation (21)
Bankruptcy (312)
Best Places to Work (9968)
BIOSECURE Act (15)
Biosimilars (113)
Biotechnology (63)
Bladder cancer (109)
Brain cancer (39)
Breast cancer (387)
Cancer (3154)
Cardiovascular disease (273)
Career advice (2075)
Career pathing (34)
CAR-T (192)
CDC (36)
Cell therapy (506)
Cervical cancer (23)
Clinical research (60886)
Collaboration (1003)
Company closure (4)
Compensation (440)
Complete response letters (39)
COVID-19 (2532)
CRISPR (60)
C-suite (488)
Cystic fibrosis (100)
Data (3546)
Decentralized trials (2)
Denatured (9)
Depression (91)
Diabetes (369)
Diagnostics (5869)
Digital health (22)
Diversity (6)
Diversity, equity & inclusion (39)
Drug discovery (146)
Drug pricing (131)
Drug shortages (26)
Duchenne muscular dystrophy (169)
Earnings (57098)
Editorial (47)
Employer branding (19)
Employer resources (131)
Events (78242)
Executive appointments (897)
FDA (15733)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (912)
Gene editing (133)
Generative AI (26)
Gene therapy (427)
GLP-1 (821)
Government (4290)
Grass and pollen (6)
Guidances (326)
Healthcare (16137)
HIV (41)
Huntington's disease (30)
IgA nephropathy (50)
Immunology and inflammation (196)
Immuno-oncology (14)
Indications (42)
Infectious disease (2722)
Inflammatory bowel disease (152)
Inflation Reduction Act (10)
Influenza (74)
Intellectual property (144)
Interviews (530)
IPO (12776)
IRA (49)
Job creations (2609)
Job search strategy (1685)
Kidney cancer (15)
Labor market (41)
Layoffs (477)
Leadership (30)
Legal (5815)
Liver cancer (79)
Longevity (9)
Lung cancer (482)
Lymphoma (233)
Machine learning (18)
Management (51)
Manufacturing (421)
MASH (116)
Medical device (10848)
Medtech (10864)
Mergers & acquisitions (15913)
Metabolic disorders (923)
Multiple sclerosis (105)
NASH (23)
Neurodegenerative disease (158)
Neuropsychiatric disorders (45)
Neuroscience (2338)
NextGen: Class of 2025 (5527)
Non-profit (4004)
Now hiring (44)
Obesity (445)
Opinion (245)
Ovarian cancer (106)
Pain (133)
Pancreatic cancer (135)
Parkinson's disease (188)
Partnered (20)
Patents (339)
Patient recruitment (254)
Peanut (46)
People (51446)
Pharmaceutical (21)
Pharmacy benefit managers (14)
Phase I (18712)
Phase II (26778)
Phase III (20419)
Pipeline (2280)
Policy (217)
Postmarket research (2316)
Preclinical (7690)
Press Release (61)
Prostate cancer (152)
Psychedelics (47)
Radiopharmaceuticals (224)
Rare diseases (511)
Real estate (4138)
Recruiting (57)
Regulatory (19982)
Reports (30)
Research institute (2130)
Resumes & cover letters (359)
Rett syndrome (12)
RNA editing (11)
RSV (50)
Schizophrenia (112)
Series A (153)
Series B (111)
Service/supplier (3)
Sickle cell disease (66)
Special edition (14)
Spinal muscular atrophy (146)
Sponsored (33)
Startups (2768)
State (2)
Stomach cancer (15)
Supply chain (73)
Tariffs (64)
The Weekly (51)
Vaccines (805)
Venture capital (49)
Weight loss (293)
Women's health (39)
Worklife (18)
Date
Today (97)
Last 7 days (385)
Last 30 days (1913)
Last 365 days (27160)
2025 (19029)
2024 (30702)
2023 (34520)
2022 (45065)
2021 (48409)
2020 (46745)
2019 (39825)
2018 (30160)
2017 (27060)
2016 (25768)
2015 (30118)
2014 (22591)
2013 (18334)
2012 (19592)
2011 (20620)
2010 (18223)
Location
Africa (731)
Alabama (64)
Alaska (5)
Arizona (162)
Arkansas (11)
Asia (34695)
Australia (7141)
California (7173)
Canada (2378)
China (715)
Colorado (302)
Connecticut (283)
Delaware (204)
Europe (76891)
Florida (1155)
Georgia (239)
Idaho (52)
Illinois (584)
India (36)
Indiana (347)
Iowa (14)
Japan (241)
Kansas (98)
Kentucky (25)
Louisiana (15)
Maine (53)
Maryland (1008)
Massachusetts (4960)
Michigan (234)
Minnesota (388)
Mississippi (3)
Missouri (92)
Montana (20)
Nebraska (22)
Nevada (87)
New Hampshire (67)
New Jersey (2081)
New Mexico (20)
New York (1975)
North Carolina (981)
North Dakota (6)
Northern California (3212)
Ohio (209)
Oklahoma (7)
Oregon (26)
Pennsylvania (1501)
Puerto Rico (17)
Rhode Island (32)
South America (997)
South Carolina (39)
South Dakota (1)
Southern California (2834)
Tennessee (112)
Texas (1159)
United States (26091)
Utah (234)
Virginia (185)
Washington D.C. (60)
Washington State (596)
West Virginia (4)
Wisconsin (54)
558,051 Results for "reshape lifesciences formally known as enteromedics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
August 8, 2025
·
3 min read
Press Releases
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
August 14, 2025
·
3 min read
Press Releases
Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
September 10, 2025
·
2 min read
Layoffs
HHS Begins Formally Laying Off Employees
Thousands of employees across HHS were terminated Monday evening after the U.S. Supreme Court ruled last week that the Trump administration could move forward with its sweeping reorganization of the agency.
July 15, 2025
·
2 min read
·
Tristan Manalac
CDC
CDC Scientist Resigns in Protest as Kennedy Reshapes Vaccine Regulation
HHS Secretary Robert F. Kennedy Jr.’s actions in recent months have raised concerns that he is taking a heavy-handed and unilateral approach to vaccine policy in the U.S.
June 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains
September 12, 2025
·
4 min read
MASH
7 Late-Stage MASH Candidates That Could Reshape the Market
Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by 2033.
April 7, 2025
·
6 min read
·
Ben Hargreaves
Press Releases
Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania
August 13, 2025
·
5 min read
Press Releases
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
June 25, 2025
·
5 min read
Press Releases
PNRI Podcast Explores How Rare Disease Research Is Reshaping Medicine for All
May 28, 2025
·
2 min read
1 of 55,806
Next
